A phase II study for the evaluation of quinine as a modulator of multidrug resistance in non-Hodgkin's lymphoma.
Soubeyran
Pierre
P
Département de Médecine, Institut Bergonié, Bordeaux, France.
Masmoudi
Amine
A
Blanc-Bisson
Christelle
C
Quénel
Nathalie
N
Hoerni
Bernard
B
Bellott
Ricardo
R
Robert
Jacques
J
Soubeyran
Isabelle
I
Donamaria
Catherine
C
Molimard
Matthieu
M
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018432:Drug Resistance, Multiple / Q000187:drug effects*; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008875:Middle Aged; D011803:Quinine / Q000627:therapeutic use*
D011803:Quinine